Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Interventional × Intestinal Neuroendocrine Tumor × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Breast Neoplasms 6349 Neoplasms 3978 Prostatic Neoplasms 3095 Colorectal Neoplasms 2575 Carcinoma, Non-Small-Cell Lung 2456 Lung Neoplasms 2223 Leukemia, Myeloid, Acute 1720 Pancreatic Neoplasms 1655 Multiple Myeloma 1591 Carcinoma, Hepatocellular 1507 Neoplasm Metastasis 1380 Stomach Neoplasms 1320 Lymphoma 1286 Head and Neck Neoplasms 1251 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1250 Brain Neoplasms 1223 Ovarian Neoplasms 1184 Melanoma 1180 Leukemia 1160 Rectal Neoplasms 1100 Recurrence 1085 Colonic Neoplasms 1040 Glioblastoma 1014 Uterine Cervical Neoplasms 932 Lymphoma, Non-Hodgkin 932 Leukemia, Lymphocytic, Chronic, B-Cell 857 Esophageal Neoplasms 842 Lymphoma, Follicular 810 Lymphoma, Large B-Cell, Diffuse 804 Myelodysplastic Syndromes 794

Interventions

Serum Albumin 1 Data Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06876532 2025-11-18

LUTIBI

Institut Claudius Regaud

Phase NA Recruiting

Intestinal Neuroendocrine Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡